logo_web
  • Clinical Trials
    • Management of medication
    • Management of reimbursement of expenses to patients
    • Supply of medical devices
    • Destruction
    • Calibration of medical devices
    • Import and labeling of medication
    • Masking. Placebos manufacturing
  • Blog
  • Quality
    • Certifications
    • RSE
  • Clients
  • Patient Reimbursement Forms
    • Validation / Expense Reimbursement Sheet
✕
  • Clinical Trials
    • Management of medication
    • Management of reimbursement of expenses to patients
    • Supply of medical devices
    • Destruction
    • Calibration of medical devices
    • Import and labeling of medication
    • Masking. Placebos manufacturing
  • Blog
  • Quality
    • Certifications
    • RSE
  • Clients
  • Patient Reimbursement Forms
    • Validation / Expense Reimbursement Sheet

Ayuso announces a 34% increase in investment in scientific research, reaching €752 million

The Community of Madrid aims to strengthen research excellence, attract talent, and consolidate the region as a national and international benchmark in this field.

consalud.es

The Community of Madrid will increase investment in scientific research by 34% with the aim of strengthening research excellence, attracting talent, and consolidating the region as a national and international benchmark in this field. The head of the regional government, Isabel Díaz Ayuso, announced today in the regional assembly that the Governing Council will approve the VII Regional Plan for Scientific Research and Technological Innovation (PRICIT) next week, with a budget of €752 million and valid until 2029.

Pulse aquí

The Plan is structured around six pillars, with six strategic objectives and eight programs aimed at strengthening the attraction and retention of talent, internationalization, and the modernization of the innovation system. The main lines of action include budget increases for Excellent Research initiatives, which are up 40%, and the Talent program, which is up 29%.

Among the main new features are the creation of a line of grants for the incorporation of highly qualified professionals and the improvement of the pre-doctoral research staff program, which increases its funding to improve both the remuneration and the additional amount they receive for short stays abroad and tuition fees.

In addition, the new Amable Liñán initiative will be launched, aimed at providing financial support to young postdoctoral researchers with international experience, in addition to the Madrid Gabriela Morreale Plan, aimed at hiring top-level researchers for strategic projects. These measures will prioritize academic excellence and the consolidation of emerging groups.

Among the main new features are the creation of a line of aid for the incorporation of highly qualified professionals and the improvement of the pre-doctoral research staff program.

New measures in the area of internationalization are also included, such as the introduction of a specific grant for the recruitment of personnel specialized in drafting European proposals, an instrument to finance proposals rated as excellent by the European Research Council, and the hiring of R&D experts based in Brussels. According to the Community of Madrid, these proposals will increase success rates, financial returns, and the region’s strategic positioning in the European and global research landscape.

It will also facilitate agreements with public universities to finance initiatives to attract talent, research projects, and the reinforcement and modernization of their scientific and technological equipment. Similarly, transparency and administrative simplification will be increased by improving processes through digitization, expanding information and transparency to achieve greater efficiency in the management of aid programs.

Related entries

5 March, 2026

The pharmaceutical industry almost triples its investment in Spain


Leer más
4 March, 2026

35,000 new patients treated, 18,000 jobs created, and three million sick days avoided: the benefits of meeting EU targets for attracting clinical trials


Leer más
9 February, 2026

Artificial intelligence enables more accurate stratification of breast cancer risk


Leer más

Recent Posts

  • Ayuso announces a 34% increase in investment in scientific research, reaching €752 million
  • The pharmaceutical industry almost triples its investment in Spain
  • 35,000 new patients treated, 18,000 jobs created, and three million sick days avoided: the benefits of meeting EU targets for attracting clinical trials
  • Artificial intelligence enables more accurate stratification of breast cancer risk
  • From potential to results: how pharmaceutical companies measure the impact of AI on their forecasts

Contacta con nosotros


Tfno: +34 955.77.67.67
Fax: +34 955.77.65.56
info@distefar.net


Distefar del Sur
Sede Central

Distefar del Sur S.L.
Av. Umbrete, 58,
41110 Bollullos de la Mitación, Sevilla

Sede Madrid

Calle de Zurbano, 45, 28010 Madrid

CENTRAL

Pol. PIBO. Avda. de Gines, 14
+34 955 776 767 /+34 692 454 913
41110 Bollullos de la Mitación (Sevilla)

MADRID DELEGATION

+34 674 575 115
28010 Madrid

Links of interest

  • Legal warning
  • Privacy policy
  • Cookies policy
  • Contact

© 2026 Distefar del Sur SL. All rights reserved. agencianodo.com

  • No translations available for this page
  • Contact
  • Private Zone
  • English

    [recaptcha]

    In accordance with the provisions of Regulation (EU) 2016/679 and Organic Law 3/2018 regarding Data Protection, we inform you that the data you provide in this form will be incorporated into a file owned by DISTEFAR DEL SUR, SL domiciled in the C / Umbrete 58, (Pol. Ind. Pibo), 41110 of Bollullos de la Mitación (Seville), in order to manage your request.

    In this regard, and if you wish to exercise your rights of access, rectification, cancellation, opposition, portability and limitation, please send a written communication to DISTEFAR DEL SUR, SL, to the address indicated above or to info@distefar.com, attaching copy of your National Identity Document or equivalent identification document.

    Basic information about Data Protection

     Epigraph

    Basic information Data Protection

    Responsable

    DISTEFAR DEL SUR, S.L.

    Purpose

    Process your inquiry / request
    Detailed information on Data Protection

    Legitimation

    Consent
    Detailed information on Data Protection

    Recipients

    It is not expected to carry out data communications to third parties, except legal obligation
    Transfers of data to third countries outside the European Union will not be carried out
    Detailed information on Data Protection

    Rights

    You have the right of access, rectification, deletion, portability of your data, as well as limitation or opposition to your treatment, as detailed in Detailed information on Data Protection

    Additional Information

    You can consult the additional and detailed information on data protection by clicking here Detailed information on Data Protection

    All the data requested / The fields marked with * in the form are mandatory, if not filled in DISTEFAR DEL SUR, S.L. will not be able to meet your request.